DIDisease IntelligenceHealthcare intelligence platform · Part of ESINED Group
Try live demo
Live ExperienceTry the end-to-end intelligence journeyDI CommandOperate the intelligence layerProduction Control PlaneIdentity, connectors, quality and enterprise readiness What we provideProducts by audience Patients & publicPhysicians & practicesHospitals & health systemsPharma & CROsResearchers & universitiesGovernment & public health Health Intelligence TerminalSearch the connected intelligence layerGraph ExplorerTraverse diseases, capabilities, evidence and researchGlobal Disease AtlasGlobal Health IntelligenceHealthcare orchestrationHealthcare exchange Dashboard demosCompare productsPricingImplementationAPI & integrationsTrust CentrePartnersWhatsApp
Disease Intelligence Mission Control

Clinical-grade intelligence.Extraordinary to operate.

A premium command environment for patients, clinicians, hospitals, research, life sciences and public health. The interface stays visually powerful while evidence, provenance, pathways, ownership and safety remain explicit.

Enter Mission ControlExplore 25 workspacesInspect 22 algorithms
Synthetic public demoGraph-nativeEvidence-separatedHuman review boundariesNo clinical decisions
DI Mission Control · Clinical operations viewSynthetic live
Verified capabilities326
Evidence objects1.2M
Condition concepts12.4K
Referral closure91%
Evidence freshness94%
Network gaps7
Observed vs forecast demandCapacity planning signal
ObservedForecast
Priority service linesCurrent routing pressure
DomainCoverageState
Endocrine / PCOS84 orgsHealthy
Allergy / Immunology71 orgsHealthy
ADHD / Neurodevelopment52 orgsWatch
Varicella / Shingles33 orgsWatch
Evidence, pathways, capabilities and network signals shown in one operating layer.Designed to look credible for serious buyers.
DI
Mission ControlClinical intelligence environment
⌕
GraphAlgorithms
Network footprint96 countries+11 active markets
Verified organisations8,342+146 / 30d
Deployment readiness87%+6pp quarter
Critical exceptions42 governance · 2 connector
Network maturity by quarterCoverage · verification · interoperability
Q1Q2Q3Q4
Verified coverageIntegration maturity
Board-level exceptionsPrioritised
Data-quality SLORare disease capability freshness below target
WATCH
Partner activationTwo institutions waiting on network agreement
ACTION
Connector riskOne external terminology connector in degraded state
REVIEW
Clinical governanceEvidence conflict cluster awaiting adjudication
REVIEW
Open referrals286-4.1%
Referral SLA91.2%+2.4pp
Median route time2.4d-0.3d
Capacity alerts73 high
Evidence freshness94.6%+1.7pp
Governance reviews125 due
Network partners418+9 / 30d
Critical safety flags0clear
Service-line pressureDemand / capacity
79
63
91
72
88
Referral queueOldest first
PathwayAgeState
Neurodevelopment4.8dReview
Rare disease3.9dGap
Oncology1.4dActive
Allergy0.8dActive
Governance signalsCurrent
Evidence conflict detectedOne pathway contains differing guideline signals
REVIEW
Provider verification expiring7 records within 30-day window
7
Connector freshness restoredTrial feed back within SLO
OK
DI> query "PCOS european specialist network"
RESOLVE canonical concept: Polycystic ovary syndrome
GRAPH 326 typed relationships traversed
EVIDENCE 148 guideline/publication objects in active context
CAPABILITY 84 organisations with relevant endocrine/gynaecology capability
ACCESS 31 remote-review routes · 19 referral-required
RESEARCH 42 trial / investigator signals
QUALITY evidence freshness 94.6% · provider freshness 88.1%
BOUNDARY clinical decision remains subject to qualified human review

DI> open graph --concept PCOS --region EU --verified-only
Ranked intelligence objectsExplainable retrieval
ObjectConfidenceFresh
Endocrinology capability cluster0.9412d
PCOS guideline evidence set0.9218d
Remote-review network route0.897d
Research / trial cluster0.861d
Change signal3 new trial-site relationships detected
NEW
Coverage gapMENA rare-disease verification remains low
GAP
Selected workspace

Hospital Operations & Capacity

·

Connected clinical intelligence graph

Relationship context, not a decorative chart
Open full Graph Explorer →

Evidence confidence

Separate dimensions
Inspect →
92%

Priority work queue

Ownership and due state

DI Signal

Meaningful change, not notification noise

Observed + forecast

Synthetic operational trend

From signal to accountable outcome

Context preserved across the workflow
Algorithm modules support retrieval, matching, routing, forecasting and quality control. Consequential clinical actions remain subject to appropriate human review, validation and governance.
A BETTER DEFINITION OF “CLINICAL”

Clinical credibility without making the product visually dull.

Clinical design here means disciplined information hierarchy, visible evidence state, traceable actions and controlled alert semantics. The experience can still feel premium, immersive and unmistakably Disease Intelligence.

25 specialised workspaces

From oncology and paediatrics to command centres, trials, research and national planning.

22 algorithm modules

Terminology, hybrid retrieval, evidence fusion, routing, forecasting, graph pathfinding, calibration and safety.

Graph at the core

Metrics and workflows pivot into the connected intelligence graph rather than ending at a static chart.

Evidence before aesthetics

Visual polish never hides provenance, freshness, uncertainty or the difference between observed and synthetic data.

Explore every specialised dashboard

Open oncology, allergy, emergency care, rare disease, diagnostics, trial operations, public health and more.

Open 25-workspace gallery